Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000351863 | SCV000342530 | uncertain significance | not provided | 2016-09-15 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000819568 | SCV000960235 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2018-07-17 | criteria provided, single submitter | clinical testing | This sequence change affects an acceptor splice site in intron 111 of the TTN gene. It is expected to disrupt RNA splicing. While this is not anticipated to result in nonsense mediated decay, it is expected to create a truncated TTN protein. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant is located in the I band of TTN (PMID: 25589632). Truncating variants in this region have been shown to be highly prevalent in the general population and unaffected individuals (PMID: 26701604, 22335739). However, truncating variants in this region have also been reported in individuals affected with autosomal recessive centronuclear myopathy (PMID: 23975875). This variant has not been reported in the literature in individuals with TTN-related disease. ClinVar contains an entry for this variant (Variation ID: 288424). |
Practice for Gait Abnormalities, |
RCV002226704 | SCV002505687 | likely pathogenic | Tip-toe gait | 2022-01-19 | no assertion criteria provided | clinical testing |